SCA
DGX icon

SAC Capital Advisors’s Quest Diagnostics DGX Stock Holding History

SAC Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-110,044
Closed -$6.37M – 286
2014
Q1 		$6.37M Buy
110,044
+46,349
+73% +$2.48M 0.03% 517
2013
Q4 		$3.41M Buy
63,695
+59,393
+1,381% +$3.52M 0.02% 575
2013
Q3 		$266K Sell
4,302
-6,318
-59% -$378K ﹤0.01% 1454
2013
Q2 		$644K Buy
+10,620
New +$633K ﹤0.01% 1022

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAC Capital Advisors's DGX Position: Q2 2014 in Review

SAC Capital Advisors sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 110,044 shares — an estimated $6.37M sold.

SAC Capital Advisors first reported a position in DGX in Q2 2013 and held it in 4 quarters. The position peaked at $6.37M in Q1 2014. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • SAC Capital Advisors reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 110,044 Quest Diagnostics shares in Q2 2014, an estimated $6.37M.
  • SAC Capital Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Quest Diagnostics position peaked at $6.37M in Q1 2014.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.